TPE:4178

2 stories mentioning TPE:4178Updated 1d ago

Every FINWIRES story that references TPE:4178, newest first.

StemCyte International Unit OKs $5 Million Cash Capital Increase

StemCyte International (TPE:4178) said its major unit StemCyte approved a cash capital increase of $4.7 million to boost working capital.The new shares will carry the same rights as existing shares and will be fully subscribed by parent company StemCyte International, according to a Wednesday Taiwan Exchange filing.StemCyte International is a regenerative therapeutics and umbilical cord blood banking company in Taiwan.

TPE:4178

Asia17d ago

StemCyte International Names Co-CEO

StemCyte International (TPE:4178) appointed Lu Kung-Ming as co-chief executive officer on Friday, according to a same-day Taiwan Exchange filing.Shares of the regenerative therapeutics and cord blood banking company gained over 1% in Monday's late afternoon trade.Lu joins the company in a newly created co-CEO role and currently serves as chairman of Xin Yao Biotechnology Investment.

TPE:4178

Track with the FINWIRES app suite

FolioX

Track TPE:4178 in your portfolio

WheelAI

Analyze TPE:4178 options with the wheel strategy

StockInsider

See market sentiment on TPE:4178